Repare Therapeutics Inc (RPTX) current stock price is $5.02. During the last trading session, the stock soared, reaching $5.69 after opening at $5.69. The stock’s lowest point was $4.96 before it closed at $5.56.
In terms of market performance, Repare Therapeutics Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $18.68 on 11/18/22, while the lowest value was $3.08 on 10/31/23.
52-week price history of RPTX Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Repare Therapeutics Inc’s current trading price is -73.13% away from its 52-week high, while its distance from the 52-week low is 62.99%. The stock’s price range for this period has remained between $3.08 and $18.68. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.6 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.29 million over the last three months.
Financial Performance and Market Capitalization
Repare Therapeutics Inc (RPTX) has experienced a quarterly decline of -51.45% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 211.49M and boasts a workforce of 180 employees.
Analysts’ Ratings For Repare Therapeutics Inc
As of right now, 6 analysts are rating Repare Therapeutics Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 8.56, with a change in price of -6.53. Similarly, Repare Therapeutics Inc recorded 223,778 in trading volume during the last 100 days, posting a change of -56.54%.
RPTX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RPTX stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.
RPTX Stock Stochastic Average
As of today, the raw stochastic average of Repare Therapeutics Inc over the past 50 days is 18.01%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 74.33%. Additionally, the Stochastic %K and %D values for the company were 86.66% and 73.30%, respectively, over the past 20 days.
RPTX Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded a decrease of -65.87%. However, over the last six months, the performance has been stronger by -46.99%. The price of RPTX increased 11.06% over the last 30 days. And in the last five days, it has surged by 30.73%.